Related Experiment Video
Updated: Nov 21, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment
Duo-Duo Lv1, Ling-Yun Zhou1, Hong Tang2
1Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China.
Abstract:
Hepatocyte nuclear factor 4α (HNF4α), a member of the nuclear receptor superfamily, is described as a protein that binds to the promoters of specific genes. It controls the expression of functional genes and is also involved in the regulation of numerous cellular processes. A large number of studies have demonstrated that HNF4α is involved in many human malignancies. Abnormal expression of HNF4α is emerging as a critical factor in cancer cell proliferation, apoptosis, invasion, dedifferentiation, and metastasis. In this review, we present emerging insights into the roles of HNF4α in the occurrence, progression, and treatment of cancer; reveal various mechanisms of HNF4α in cancer (e.g., the Wnt/β-catenin, nuclear factor-κB, signal transducer and activator of transcription 3, and transforming growth factor β signaling pathways); and highlight potential clinical uses of HNF4α as a biomarker and therapeutic target for cancer.
Insights
Hepatocyte nuclear factor 4α (HNF4α) plays a key role in cancer development and progression. Understanding its functions offers new strategies for cancer therapy and biomarker development.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Hepatocyte nuclear factor 4α (HNF4α) is a nuclear receptor protein regulating gene expression and cellular processes.
- Abnormal HNF4α expression is linked to various human cancers, influencing proliferation, apoptosis, invasion, and metastasis.
Purpose of the Study:
- To review the multifaceted roles of HNF4α in cancer occurrence, progression, and treatment.
- To elucidate the molecular mechanisms underlying HNF4α's involvement in cancer.
- To highlight the clinical potential of HNF4α as a cancer biomarker and therapeutic target.
Main Methods:
- Literature review of studies on HNF4α in human malignancies.
- Analysis of HNF4α's involvement in key cancer signaling pathways.
- Evaluation of HNF4α's potential as a clinical biomarker and therapeutic target.
Main Results:
- HNF4α is critically involved in cancer cell proliferation, apoptosis, invasion, dedifferentiation, and metastasis.
- HNF4α influences cancer through pathways including Wnt/β-catenin, NF-κB, STAT3, and TGF-β.
- Emerging evidence supports HNF4α's utility as a biomarker and therapeutic target in oncology.
Conclusions:
- HNF4α is a significant factor in human cancer, impacting multiple hallmarks of the disease.
- Targeting HNF4α and its associated pathways presents a promising avenue for cancer treatment.
- Further research into HNF4α's clinical applications could lead to improved cancer diagnostics and therapeutics.
More Related Videos
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply

